Castleview Partners’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Castleview Partners’s Portfolio TMDI Stock Details TMDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$660	–	726
2022 Q4	$660	Hold	1,000	–	–	﹤0.01%	576
2022 Q3	$0	Buy	1,000 +606	+154%	+$314	﹤0.01%	789
2022 Q2	$66.6K	Sell	394 -606	-61%	-$297	0.05%	261
2022 Q1	$0	Buy	1,000 +375	+60%	+$217	﹤0.01%	1058
2021 Q4	$1K	Buy	+625	New	+$704	0.01%	399
2021 Q2	$2K	Buy	+1,000	New	+$1.72K	﹤0.01%	872

Other funds holding TMDI

Essex LLC Deer Park, Illinois $659M AUM 41.98% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

Waterford Advisors Orchard Park, New York $315M AUM 15.21% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

MCA

Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return

DIS

Diversified Investment Strategies Baton Rouge, Louisiana $157M AUM 24.09% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Castleview Partners's TMDI Position: Q1 2023 in Review

Castleview Partners sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 1,000 shares — an estimated $660 sold.

Castleview Partners first reported a position in TMDI in Q2 2021 and held it in 6 quarters. The position peaked at $66.6K in Q2 2022. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

Castleview Partners reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Castleview Partners sold 1,000 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $660.
Castleview Partners first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2021 and held it in 6 quarters.
Castleview Partners's Titan Medical Inc. Ordinary Shares position peaked at $66.6K in Q2 2022.
12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on Castleview Partners's 13F filing for Q1 2023, filed 16 May 2023.